Many insured cancer patients pay no OOP costs for genetic counseling

Mya L. Roberson, Ph.D., from the Vanderbilt University School of Medicine, in Nashville, Tennessee, and colleagues used data from the IBM Watson Health MarketScan database to identify 16,791 privately insured patients with breast, prostate, endometrial, ovarian, colorectal, or pancreatic cancer, who had at least one encounter for genetic counseling from 2013 through 2019. The researchers […]

Continue Reading

New therapeutic drug for Alzheimer’s disease without inflammatory side effects

Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA approved drug for Alzheimer’s disease (AD) based on its ability to decrease Aβ plaque burden in AD patients, its effect on cognitive improvement is still controversial. Moreover, about 40% of the patients treated with this antibody experienced serious side effects […]

Continue Reading

Barriers to advance care planning identified for sexual and gender minorities

Discrimination in the health care system is an important barrier to advance care planning for sexual and gender-minority (SGM) people, according to a study published online July 20 in JAMA Network Open. Amanda Jane Reich, Ph.D., from Brigham and Women’s Hospital in Boston, and colleagues examined barriers and facilitators to advance care planning discussions among […]

Continue Reading